Sunday November 22 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Bio-Technology General Corporation

Bio-Technology General Corp. has established itself as a leader in the biopharmaceutical industry with superior capabilities in the research, development, and manufacturing of recombinant proteins, as well as capabilities in small molecule technology.

Through a combination of internal research and development, acquisitions, collaborative relationships, and licensing arrangements, we have successfully developed a diverse portfolio of therapeutic products directed at serving the underserved in both niche and wider markets.



Our goal is to leverage the scientific expertise and financial stability that we have achieved to date with our commercial products worldwide, to take advantage of new opportunities that will enable us to continue to seek out and provide solutions to some of the greatest health care challenges of today.



The company's corporate administration, licensing, human clinical studies, marketing and sales activities, quality assurance, and regulatory affairs are primarily coordinated at our headquarters in Iselin, New Jersey. Pre-clinical studies, research and development activities, and manufacturing of our biotechnology derived products are carried out through Bio-Technology General (Israel) Ltd., our wholly owned subsidiary, in Rehovot, Israel.


Contact Details:
70 Wood Avenue South
Iselin
NJ
08830
United States of America
Tel:732 632 8800
Fax:732 632 8844
Email:

Loading...

Recent Publications by Bio-Technology General Corporation:

Molecular characterization of a human monoclonal antibody that interacts with a sulfated tyrosine-containing epitope of the GPIb receptor and inhibits platelet functions.
Modification of tyrosine residues in extracellular proteins by a sulfate...
24th February, 2006
Bio-Technology General (Israel) Ltd., Research Department, Kiryat Weizmnn, Mol Immunol. 2006 Feb;43(5):443-53. Epub 2005 Apr 7.
DOI Direct Link
Function-modulating human monoclonal antibodies against platelet-membrane receptors isolated from a phage-display library.
Monoclonal antibodies to platelet membrane receptors have been used...
10th April, 2004
Bio-Technology J Thromb Haemost. 2003 Aug;1(8):1829-36.

BioNews Results for Bio-Technology General Corporation:

Lumenis Introduces Advanced Retinal Laser Delivery Technology at the 2009 American Academy of Ophthalmology Annual Meeting in San Francisco, California, USA
SmartBrief:  Oct 29 2009 7:16AM Matching: bio technology general
AusBiotech 2009: Int'l Biotech Showcase Has Begun
Scoop:  Oct 28 2009 1:51AM Matching: bio technology general
Savient Pharmaceuticals Inc - SWOT Analysis
TMC Net:  Oct 24 2009 6:43PM Matching: bio technology general
Universal Detection Technology Anthrax Detection Equipment Approved on New York State H.I.R.E. Contract, Distr
Freshnews.com:  Oct 20 2009 10:12AM Matching: bio technology general
Universal Detection Technology Anthrax Detection Equipment Approved on New York State H.I.R.E. Contract, Distr
Genetic Engineering News:  Oct 20 2009 9:46AM Matching: bio technology general
Promote your company here: BioNewsCast - Press Release Distribution

View more Bio-Technology General Corporation news.

Bio-Technology General Corporation Patents:

US Patent No.Title
5198361 Plasmids for production of met-asp-gln bovine growth hormone, hosts containing the plasmids, products manufactured thereby and related methods
5527691 Expression vectors containing lambdapl promoter and T.sub.1 T.sub.2 rRNA termination sequence, plasmids containing the vectors, hosts containing the plasmids and related methods
5540911 Methods of use of human manganese superoxide dismutase
5548068 Somatotropins with alterations in the alpha-helix 1 region, and combinations with other mutations
5593860 Expression plasmids containing the deo promoter, and bacterial hosts containing the plasmids

View more Bio-Technology General Corporation patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 873 times since April 2007, the link to the organisation's website has been followed 0 times

Recent Search Terms used to find this page: gen corp nj market research | bio technology general israel product s US | bio-technology general products | Bio-Technology General Corporation- Iselin | technology General corporation | bio-technology general website | Bio-Technology General | Bio-Technology General Israel Ltd. commercial register | biotechnology general | Biotechnology General website | .

Search for more companies in Iselin

Search for more companies in NJ



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Bio-Technology General Corporation

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.